• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状 COVID-19 患者的致命性肺血栓栓塞症。

Fatal pulmonary thromboembolism in asymptomatic COVID-19.

机构信息

School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.

Department of Histopathology, Beaumont Hospital, Dublin, Ireland.

出版信息

Ir J Med Sci. 2022 Aug;191(4):1777-1783. doi: 10.1007/s11845-021-02735-8. Epub 2021 Sep 5.

DOI:10.1007/s11845-021-02735-8
PMID:34482482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8418686/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) has claimed the lives of millions of people globally.

AIMS

This study aims to identify the pathological findings at autopsy of asymptomatic COVID-19 death, to compare the incidence of acute bilateral pulmonary thromboembolism (ABPTE) in asymptomatic COVID-19 deaths versus non-COVID-19 deaths and to explore the possible pathogenesis of thrombosis in COVID-19. We also consider the place of COVID-19 in the death certification of 4 cases who died from ABPTE.

METHODS

This study primarily reviewed post-mortem reports of 6 asymptomatic COVID-19 deaths. Post-mortem reports for the years 2019 and 2020 were also reviewed to establish the incidence of ABPTE. Each post-mortem report was reviewed for gross examination, histology and toxicology findings. A literature review on COVID-19 autopsy findings, COVID-19 pathogenesis, thrombosis in COVID-19 and asymptomatic SARS-CoV-2 infection was also conducted using PubMed.

RESULTS

Of the 6 asymptomatic COVID-19 deaths, 4 died as a result of ABPTE, 1 died of ischaemic and hypertensive cardiac disease caused by coronary artery disease and ventricular hypertrophy and the remaining case died of heart failure due to dilated cardiomyopathy caused by subendocardial fibrosis. There were 2 cases of bilateral pulmonary thromboembolism (BPTE) in 2019 out of 140 post-mortems. Excluding the 4 cases of ABPTE described already, there was 1 case of ABPTE in 2020 out of 156 post-mortems. A literature review on the pathogenesis of thrombosis in COVID-19 highlighted the significant role that the endothelium plays.

CONCLUSIONS

Massive pulmonary thromboembolism may be a significant cause of death in asymptomatic COVID-19 infection.

摘要

背景

2019 年冠状病毒病(COVID-19)已在全球夺走数百万人的生命。

目的

本研究旨在确定无症状 COVID-19 死亡患者的尸检病理发现,比较无症状 COVID-19 死亡与非 COVID-19 死亡患者急性双侧肺血栓栓塞症(ABPTE)的发生率,并探讨 COVID-19 中血栓形成的可能发病机制。我们还考虑了 COVID-19 在因 ABPTE 而死亡的 4 例患者的死亡证明中的地位。

方法

本研究主要回顾了 6 例无症状 COVID-19 死亡患者的尸检报告。还回顾了 2019 年和 2020 年的尸检报告,以确定 ABPTE 的发生率。对每份尸检报告进行了大体检查、组织学和毒理学检查。还使用 PubMed 对 COVID-19 尸检发现、COVID-19 发病机制、COVID-19 中的血栓形成和无症状 SARS-CoV-2 感染的文献进行了综述。

结果

在 6 例无症状 COVID-19 死亡患者中,4 例死于 ABPTE,1 例死于由冠状动脉疾病和心室肥大引起的缺血性和高血压性心脏病,其余 1 例死于由心内膜下纤维化引起的扩张型心肌病导致的心衰。在 140 例尸检中,2019 年有 2 例双侧肺血栓栓塞症(BPTE)。不包括已经描述的 4 例 ABPTE 病例,2020 年 156 例尸检中有 1 例 ABPTE。对 COVID-19 中血栓形成发病机制的文献综述强调了内皮在其中的重要作用。

结论

大量肺血栓栓塞症可能是无症状 COVID-19 感染死亡的重要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/d8f432accdb3/11845_2021_2735_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/c17bd599f37d/11845_2021_2735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/bbf5df1265e2/11845_2021_2735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/9388e7c056ed/11845_2021_2735_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/9d305e3455aa/11845_2021_2735_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/d8f432accdb3/11845_2021_2735_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/c17bd599f37d/11845_2021_2735_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/bbf5df1265e2/11845_2021_2735_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/9388e7c056ed/11845_2021_2735_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/9d305e3455aa/11845_2021_2735_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3642/9308589/d8f432accdb3/11845_2021_2735_Fig5_HTML.jpg

相似文献

1
Fatal pulmonary thromboembolism in asymptomatic COVID-19.无症状 COVID-19 患者的致命性肺血栓栓塞症。
Ir J Med Sci. 2022 Aug;191(4):1777-1783. doi: 10.1007/s11845-021-02735-8. Epub 2021 Sep 5.
2
Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic.基于在 COVID-19 大流行期间 SARS-CoV-2 组织 PCR 阳性患者的系统尸检研究的死亡原因。
J Intern Med. 2021 Sep;290(3):655-665. doi: 10.1111/joim.13300. Epub 2021 May 20.
3
Higher prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: autopsy results from 'Spanish flu' 1918/1919 in Switzerland to Coronavirus disease 2019.SARS-CoV-2 肺内大血栓的发生率高于甲型流感:瑞士 1918/1919 年“西班牙流感”至 2019 年冠状病毒病的尸检结果。
J Pathol Clin Res. 2021 Mar;7(2):135-143. doi: 10.1002/cjp2.189. Epub 2020 Nov 13.
4
Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports.新冠肺炎死亡患者中的血栓栓塞事件及其可能的发病机制:来自尸检报告的教训。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1670-1679. doi: 10.26355/eurrev_202102_24878.
5
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
6
Generalized thrombosis in a patient with ongoing asymptomatic COVID-19.COVID-19 持续无症状患者的全身性血栓形成。
Soud Lek. 2021 Winter;66(4):54-57.
7
Increase in venous thromboembolism in SARS-CoV-2 infected lung tissue: proteome analysis of lung parenchyma, isolated endothelium, and thrombi.SARS-CoV-2 感染肺组织中静脉血栓栓塞的增加:肺实质、分离的内皮和血栓的蛋白质组分析。
Histopathology. 2024 May;84(6):967-982. doi: 10.1111/his.15143. Epub 2024 Jan 22.
8
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases.735 例连续 SARS-CoV-2 相关死亡病例的前瞻性尸检评估。
Sci Rep. 2021 Sep 29;11(1):19342. doi: 10.1038/s41598-021-98499-3.
9
Thromboembolic complications of COVID-19.COVID-19 相关的血栓栓塞并发症。
Emerg Radiol. 2021 Apr;28(2):423-429. doi: 10.1007/s10140-020-01868-0. Epub 2020 Nov 7.
10
[Systemic consequences and clinical aspects of SARS-CoV-2 infection].[新型冠状病毒2019感染的全身后果及临床方面]
Pathologe. 2021 Mar;42(2):155-163. doi: 10.1007/s00292-021-00913-0. Epub 2021 Feb 11.

引用本文的文献

1
Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.新冠病毒肺炎中肺动脉增宽的可逆性作为疾病缓解的标志物
J Pers Med. 2024 Jan 31;14(2):161. doi: 10.3390/jpm14020161.
2
Fatal Form of COVID-19 in a Young Male Bodybuilder Anabolic Steroid Using: The First Autopsied Case.COVID-19 致死病例:一名年轻男性健美运动员使用合成代谢类固醇:首例尸检案例。
Medicina (Kaunas). 2022 Sep 29;58(10):1373. doi: 10.3390/medicina58101373.

本文引用的文献

1
COVID-19 as the cause of thrombosis: recognising COVID-19 infection in apparently asymptomatic patients.COVID-19 导致的血栓:识别貌似无症状的 COVID-19 感染者。
BMJ Case Rep. 2021 Jan 7;14(1):e241027. doi: 10.1136/bcr-2020-241027.
2
COVID-19 is, in the end, an endothelial disease.COVID-19 归根结底是一种血管内皮疾病。
Eur Heart J. 2020 Sep 1;41(32):3038-3044. doi: 10.1093/eurheartj/ehaa623.
3
Severe COVID-19 Is a Microvascular Disease.重症新型冠状病毒肺炎是一种微血管疾病。
Circulation. 2020 Oct 27;142(17):1609-1611. doi: 10.1161/CIRCULATIONAHA.120.050354. Epub 2020 Sep 2.
4
Insidious development of pulmonary embolism in asymptomatic patients with COVID-19: Two rare case-reports.新型冠状病毒肺炎(COVID-19)无症状患者中肺栓塞的隐匿性发展:两例罕见病例报告
Respir Med Case Rep. 2020;31:101186. doi: 10.1016/j.rmcr.2020.101186. Epub 2020 Aug 11.
5
Histopathological observations in COVID-19: a systematic review.新型冠状病毒肺炎的组织病理学观察:一项系统综述
J Clin Pathol. 2021 Feb;74(2):76-83. doi: 10.1136/jclinpath-2020-206995. Epub 2020 Aug 18.
6
Fatal Pulmonary Thromboembolism in SARS-CoV-2-Infection.新型冠状病毒感染导致的致命性肺血栓栓塞症
Cardiovasc Pathol. 2020 Sep-Oct;48:107227. doi: 10.1016/j.carpath.2020.107227. Epub 2020 May 12.
7
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.COVID-19 中的细胞因子风暴:发病机制和治疗中使用的抗炎药物概述。
Clin Rheumatol. 2020 Jul;39(7):2085-2094. doi: 10.1007/s10067-020-05190-5. Epub 2020 May 30.
8
COVID-19: the vasculature unleashed.COVID-19:血管失控。
Nat Rev Immunol. 2020 Jul;20(7):389-391. doi: 10.1038/s41577-020-0343-0.
9
Covid-19 and thrombosis: what do we know about the risks and treatment?新冠病毒与血栓形成:我们对风险和治疗了解多少?
BMJ. 2020 May 21;369:m2058. doi: 10.1136/bmj.m2058.
10
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome : Results From a Prospective, Single-Center, Clinicopathologic Case Series.COVID-19 相关肺动脉血栓栓塞导致的致命结局:一项前瞻性、单中心、临床病理病例系列研究的结果。
Ann Intern Med. 2020 Sep 1;173(5):350-361. doi: 10.7326/M20-2566. Epub 2020 May 14.